Patients with dyskinesia had lower onset age ( p < 0.001 ) , longer duration of levodopa therapy ( p < 0.001 ) , longer disease duration ( p < 0.001 ) , higher total daily levodopa dose ( p < 0.001 ) , and higher total UPDRS scores ( p = 0.005 ) than patients without dyskinesia .
B-OrganismTaxon O B-DiseaseOrPhenotypicFeature O O O O O O O O O O O O O B-ChemicalEntity O O O O O O O O O O O O O O O O O O O B-ChemicalEntity O O O O O O O O O O O O O O O O O O B-OrganismTaxon O B-DiseaseOrPhenotypicFeature O